Kairos Pharma Ltd. (KAPA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kairos Pharma Ltd. (KAPA:NYSE), powered by AI.

Current Price
$0.44
Sector
Healthcare
What is the Kairos Pharma Ltd. stock price forecast?

Kairos Pharma Ltd. is currently trading at $0.44. View real-time AI analysis on Alpha Lenz.

What is Kairos Pharma Ltd. insider trading activity?

View the latest insider trading data for Kairos Pharma Ltd. on Alpha Lenz.

What is Kairos Pharma Ltd.'s P/E ratio?

View Kairos Pharma Ltd.'s valuation metrics on Alpha Lenz.

Kairos Pharma Ltd.

NYSE · KAPA
$0.44-0.02(-3.93%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Kairos Pharma Ltd.'s future dividend policy...
Alpha Chat Insight

Kairos Pharma Ltd.'s ROE is -98.0%. Explore profitability and growth together.

Ask for details

Company Overview

Kairos Pharma Ltd. is a pharmaceutical company focused on the research, development, and commercialization of innovative therapies. Its primary function is to advance treatments that target niche, unmet medical needs, particularly in the fields of oncology and degenerative diseases. The company is committed to harnessing cutting-edge scientific advancements and biotechnology, working alongside healthcare professionals and researchers to bring viable solutions to the market. Notable features include its robust pipeline of clinical trials that explore novel drug candidates and proprietary platforms aimed at improving patient outcomes. Kairos Pharma Ltd. plays a pivotal role in the healthcare sector, contributing to the development of new medications that offer hope to patients and healthcare providers alike. By addressing specialized medical demands, the company influences the pharmaceutical landscape and supports the ongoing evolution of targeted therapies.

CEODr. John S. Yu M.D., Ph.D.
SectorHealthcare
IndustryBiotechnology
Employees1

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
1Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-88.51%ROA
-97.99%ROE
-88.51%ROIC

Financial Health

$4.49MCash & Cash Equivalents
$-4.29MNet Debt
3.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kairos Pharma Ltd. (ticker: KAPA) is a company listed on NYSE in the Healthcare sector (Biotechnology). It has approximately 1 employees.

The current price is $0.44 with a P/E ratio of -x and P/B of -x.

ROE is -97.99%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kairos Pharma Ltd. (KAPA) Stock Forecast 2026 $0.44 — Price, Financials & Analyst Targets | Alpha Lenz